CHEBI:76163 - isoxicam

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name isoxicam
ChEBI ID CHEBI:76163
Definition A monocarboxylic acid amide that is piroxicam in which the pyrid-2-yl group is replaced by a 5-methyl-1,2-oxazol-3-yl group. A non-steroidal anti-inflammatory drug, it was withdrawn from the market in the 1980s following its association with cases of Stevens-Johnson syndrome.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C14H13N3O5S
Net Charge 0
Average Mass 335.33500
Monoisotopic Mass 335.05759
InChI InChI=1S/C14H13N3O5S/c1-8-7-11(16-22-8)15-14(19)12-13(18)9-5-3-4-6-10(9)23(20,21)17(12)2/h3-7,18H,1-2H3,(H,15,16,19)
InChIKey YYUAYBYLJSNDCX-UHFFFAOYSA-N
SMILES CN1C(C(=O)Nc2cc(C)on2)=C(O)c2ccccc2S1(=O)=O
Roles Classification
Biological Role(s): human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via benzothiazine )
Application(s): non-steroidal anti-inflammatory drug
An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
antirheumatic drug
A drug used to treat rheumatoid arthritis.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing isoxicam (CHEBI:76163) has role antirheumatic drug (CHEBI:35842)
isoxicam (CHEBI:76163) has role non-steroidal anti-inflammatory drug (CHEBI:35475)
isoxicam (CHEBI:76163) is a benzothiazine (CHEBI:46899)
isoxicam (CHEBI:76163) is a isoxazoles (CHEBI:55373)
isoxicam (CHEBI:76163) is a monocarboxylic acid amide (CHEBI:29347)
IUPAC Name
4-hydroxy-2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
INNs Sources
isoxicam WHO MedNet
isoxicam ChemIDplus
isoxicamo ChemIDplus
isoxicamum ChemIDplus
Synonyms Sources
4-hydroxy-2-methyl-N-(5-methyl-3-isoxazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide ChemIDplus
4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide ChEBI
BRN 0577221 ChemIDplus
EINECS 252-084-5 ChemIDplus
N-(5-methyl-3-isoxazolyl)-4-hydroxy-2-methyl-2H-1,2-benzthiazine-3-carboxamide 1,1-dioxide ChEBI
UNII-8XU734C4NG ChemIDplus
W 8495 ChemIDplus
Brand Name Source
Maxicam KEGG DRUG
Manual Xrefs Databases
1509 DrugCentral
D04639 KEGG DRUG
DE2208351 Patent
US3787324 Patent
View more database links
Registry Numbers Types Sources
34552-84-6 CAS Registry Number KEGG DRUG
34552-84-6 CAS Registry Number ChemIDplus
577221 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
1236641 PubMed citation Europe PMC
1499594 PubMed citation Europe PMC
24061247 PubMed citation Europe PMC
2575504 PubMed citation Europe PMC
2618088 PubMed citation Europe PMC
3436154 PubMed citation Europe PMC
3557542 PubMed citation Europe PMC
3620270 PubMed citation Europe PMC
3620275 PubMed citation Europe PMC
3620277 PubMed citation Europe PMC
3904436 PubMed citation Europe PMC
3904438 PubMed citation Europe PMC
6391795 PubMed citation Europe PMC
Last Modified
22 February 2017